Eli Lilly and Company entered into a definitive agreement to acquire remaining majority stake in Ajax Therapeutics, Inc. for $2.3 billion.

Published: 2026-04-27 10:20:28 ET LLY

Published on 04/27/2026 at 10:20 am EDT